Drunk Elephant announced its first artistry collective, bringing together four of the beauty industry’s most influential makeup artists to celebrate the debut of Kamo Triple-Peptide Cover Drops.
This collaboration further underscores the brand’s leadership in clinical color innovation.
Kamo Triple-Peptide Cover Drops is the newest addition to Drunk Elephant’s Clinical Color category, joining beloved D-Bronzi Anti-Pollution Sunshine Drops, O-Bloos Rosi Drops and B-Goldi Bright Drops. Drunk Elephant’s clinical color formulas are developed using clinical-grade skincare standards. Kamo Triple-Peptide Cover Drops is a multi-use formula–wear it as foundation, concealer, or tint. The multiuse complexion drop combines 18% amino-acid-coated pigments with a 4.0% peptide complex to deliver seamless, undetectable coverage while helping skin appear visibly firmer and more radiant.
The collective unites four world-renowned artists–Mali Boykin, Kelsey Deenihan, James Molloy and Kasey Spickard–each recognized for their distinct aesthetic and creative perspective. Their expertise spans celebrity and red-carpet beauty, backstage fashion, editorial artistry, trend forecasting and innovative creative direction. Together, they demonstrate the breadth of talent and creative perspectives shaping the industry today, reinforcing Drunk Elephant’s commitment to clinically driven color performance.
Through this partnership, the artists will showcase their unique approaches to complexion, color and self-expression using Kamo Triple-Peptide Cover Drops, demonstrating the versatility and skin-first philosophy that has come to define Drunk Elephant’s clinical color category.
